Monday, 30 December 2019

Investorideas.com - Cannabis Stock News: C21 Investments (CSE: CXXI) (OTCQB: CXXIF) Announces Record Q3 Revenue of $10.58 Million Adjusted EBITDA up 175%; Adjusted Operating Income up 1,900%

Investorideas.com - Cannabis Stock News: C21 Investments (CSE: CXXI) (OTCQB: CXXIF) Announces Record Q3 Revenue of $10.58 Million Adjusted EBITDA up 175%; Adjusted Operating Income up 1,900%

Investorideas.com - Cannabis Stock News: Aphria Inc. (TSX: APHA) (NYSE: $APHA) to Announce Second Quarter Fiscal 2020 Financial Results on January 14, 2020

Investorideas.com - Cannabis Stock News: Aphria Inc. (TSX: APHA) (NYSE: $APHA) to Announce Second Quarter Fiscal 2020 Financial Results on January 14, 2020

Investorideas.com - Cannabis Stock News: Khiron (TSXV: KHRN) (OTCQB: KHRNF) Welcomes Colombia's Receipt of 2020 Production Quota of 56.5 Tons of High-THC Cannabis

Investorideas.com - Cannabis Stock News: Khiron (TSXV: KHRN) (OTCQB: KHRNF) Welcomes Colombia's Receipt of 2020 Production Quota of 56.5 Tons of High-THC Cannabis

www.investorideas.com - news that inspires big ideas

Investor Ideas Potcasts; Cannabis News and Stocks on the Move; (CSE: $BEV.C), (NASDAQ: $AMRS), (TSXV: $KHRN.V), (CSE: $OILS.C), (TSX: $APHA.TO) (NYSE: $APHA)


Investor Ideas Potcasts; Cannabis News and Stocks on the Move; (CSE: $BEV.C), (NASDAQ: $AMRS), (TSXV: $KHRN.V), (CSE: $OILS.C), (TSX: $APHA.TO) (NYSE: $APHA)



Delta, Kelowna, BC, December 30, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

BevCanna Enterprises Inc. (CSE:BEV) (OTCQB: BVNNF) announced that is has increased the size of its outdoor cannabis cultivation site to 292 acres, up from the originally announced 130 acre site. BevCanna has partnered with agricultural experts Clearwater CannGrow Ltd. to grow certified organic sun-grown cannabis on the property near Osoyoos, British Columbia.

This expansion of cultivatable land will allow BevCanna to develop into one of largest outdoor cannabis cultivators in Canada. The Company has in turn increased its anticipated production to 300,000 kg - 400,000 kg of biomass, and a yield of 30,000 kg – 40,000 kg of pure cannabinoids through the finished extract.

"Interest in our BC sun grown cannabis has been exceptionally strong, and we're expanding our cultivation and production capabilities to meet the anticipated demand," said John Campbell, Chief Strategy Officer at BevCanna. "The increased capacity will position BevCanna well to become a leader in the production of high-quality, next-generation products, in the lead-up to Canada's commercialization of such products in 2020."

In conjunction with the additional cultivation capacity, BevCanna has completed a debt settlement with cultivation partner Clearwater CannGrow, in the amount of $500,000, in exchange for the issuance of 1,000,000 common shares at a deemed price of $0.50 per Share.

"We're very pleased to further strengthen our relationship with Clearwater CannGrow," said John Campbell, Chief Strategy Officer at BevCanna. "Clearwater CannGrow's direct expenditures into our agricultural operation are an incredible sign of confidence and commitment to the operation, and to BevCanna as a whole."

The Shares issued in the debt settlement are subject to resale restrictions imposed by applicable law or regulation, including a statutory hold period expiring four months and one day from the date of closing of the debt settlement.

Amyris, Inc. (NASDAQ: AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, reported that it has successfully shipped the first cannabinoid to its partner, LAVVAN. Amyris is also well on its way to the shipment of a second cannabinoid in the first half of 2020.

These ingredients are produced with Amyris's fermentation technology platform delivering the leading quality and high purity at a significantly reduced cost relative to cannabis plant grown and derived ingredients. The company's technology allows Amyris to scale ingredients that are rarer within the cannabis plant, and difficult and extremely expensive to extract in quantity. This is the 10th unique fermentation molecule Amyris has currently in production. Amyris is a market leader in Clean Beauty and natural ingredients from fermentation and currently has 22 additional molecules in development with some of the world's leading companies as partners and long-term supply and commercialization agreements to ensure successful market entry.

The company also announced that it has agreed on business terms for a partnership with a leading Asian pharmaceutical company to develop and scale a breakthrough target for a rare oncology treatment. In addition to the success in cannabinoids and the new opportunity in oncology the company has also agreed to significantly expand its current collaboration with its Chinese partner for vitamins. Amyris plans to provide further details on these agreements at an investor update meeting to be scheduled in February. These new agreements represent several millions of dollars in collaboration payments annually for the next several years. Biossance is also having an excellent quarter with Biossance.com now representing about 50% of Biossance revenue and Sephora continuing to deliver excellent growth.

"We are very pleased to end 2019 with strong operational performance and business momentum," said John Melo, President and CEO of Amyris. "We plan to continue building on our position as the leading synthetic biology company by continuing to deliver the highest purity and most sustainably sourced ingredients for the Health, Beauty and Flavor and Fragrance industries. Our brands are delivering the leading products in their respective categories and this is helping us deliver an excellent quarter. We expect to have our financing needs behind us early in 2020 and a strong year of profitable growth."

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF)  welcomed the Colombian government's announcement that the country has been awarded a record high quota of 21.84% of worldwide high -THC for commercial and scientific purposes. The quota, which is awarded by the International Narcotics Control Board ("INCB"), an independent body for the implementation of the United Nations Drug Convention, affirms Colombia's role as one of the most important supply sources for the licensed global cannabis economy.

Established in 1961, the INCB, who's members are made up of global government agencies and representatives of the World Health Organization, plays an important role in monitoring enforcement of restrictions on narcotics and psychotropics and in deciding which jurisdictions should be regulated. The quota allocation of 56.5 tons of dry flower for Colombia in 2020, affirms that the international community governing legalized narcotics recognizes the important work of the Colombia government in establishing an effective regulatory framework to support national and worldwide cannabis demand.

Juan Diego Alvarez, Khiron Vice President of Regulatory Affairs, stated "As the only company with an authorized high-THC quota for cultivation in 2019 to meet the needs of patients in Colombia, we welcome the INCB announcement and congratulate the Government of Colombia on the achievement. The 2020 quota guarantees access to new medical products that can transform patients' lives."

Khiron Life Sciences is currently the only cannabis company in Colombia with an allocation of quota to manufacture psychoactive medical cannabis for commercial domestic purposes, and one of the few companies also authorized to meet export demand. As previously announced, the authorization is a result of commercial quotas allocated to Khiron by the Colombian Technical Quotas Group ("TQG"), which permit the Company to cultivate and commercialize up to 560 kg – or approximately, 65,000 units – of psychoactive, high-THC cannabis in 2019. As of April 2019, Khiron has applied for additional commercial quotas for high-THC cannabis for 2020. TQG decisions on commercial quotas for the year are anticipated to be announced by February 2020. 

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) announced that the Canadian Intellectual Property Office has granted the Company a patent for its proprietary filtration stack used in the post-extraction processing of THC and CBD oils. Nextleaf has been issued a total of 11 patents by four international patent offices in the key markets of Canada, the United States of America, Australia, and Colombia.

"Given the abundant supply of lower-grade dried cannabis, we believe processors that establish a competitive advantage by utilizing superior technology to transform otherwise unsellable biomass into high-purity THC and CBD oils at a lower cost than competitors, will generate better margins and build a sustainable long term business," said Paul Pedersen, CEO of Nextleaf Solutions. "As we close out 2019, I'm extremely proud of our R&D team for obtaining its 11th patent, protecting what we believe to be the most efficient methods for producing distilled THC and CBD oil at scale within a regulated environment," continued Pedersen.


Aphria Inc. (TSX: APHA) (NYSE: APHA) will release their financial results for its second quarter and six months ended November 30, 2019 on January 14, 2020 before market open. 

Aphria executives will host a conference call to discuss these results at 8:00 am Eastern Time. To listen to the live call, dial (888) 231-8191 from Canada and the U.S. or (647) 427-7450 from International locations and use the passcode 1575423. A telephone replay will be available approximately two hours after the call concludes through January 28, 2020. To access the recording dial (855) 859-2056 and use the passcode 1575423.

There will also be a simultaneous, live webcast available on the Investors section of Aphria's website at aphriainc.com. The webcast will be archived for 30 days.

To hear Investorideas interview with Aphria CMO click here.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android  

Contact Investorideas.com
800-665-0411

  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory


Friday, 27 December 2019

Investorideas.com - Cannabis Stock News: Amyris (NASDAQ: $AMRS) Announces Successful Shipment of First Fermentation Derived Cannabinoid to LAVVAN and Provides Business Updates

Investorideas.com - Cannabis Stock News: Amyris (NASDAQ: $AMRS) Announces Successful Shipment of First Fermentation Derived Cannabinoid to LAVVAN and Provides Business Updates

Investorideas.com - Cannabis Stock News: Canada House Wellness Group (CSE: CHV) Reports Second Quarter Fiscal Year 2020 Results

Investorideas.com - Cannabis Stock News: Canada House Wellness Group (CSE: CHV) Reports Second Quarter Fiscal Year 2020 Results

Investorideas.com - Cannabis Stock News: Choom (CSE: CHOO; OTCQB: CHOOF) Announces Opening of Cannabis Retail Store Airdrie, Alberta

Investorideas.com - Cannabis Stock News: Choom (CSE: CHOO; OTCQB: CHOOF) Announces Opening of Cannabis Retail Store Airdrie, Alberta

Investorideas.com - Cannabis Stock News: BevCanna (CSE:BEV, Q:BVNNF) Expands Outdoor Cannabis Cultivation Capabilities to Almost 300 acres

Investorideas.com - Cannabis Stock News: BevCanna (CSE:BEV, Q:BVNNF) Expands Outdoor Cannabis Cultivation Capabilities to Almost 300 acres

www.investorideas.com - news that inspires big ideas

Friday, 20 December 2019

Investorideas.com - Cannabis Stock News: Spyder Cannabis (TSXV: SPDR) Announces MOU with HighBreed Growth has Expired

Investorideas.com - Cannabis Stock News: Spyder Cannabis (TSXV: SPDR) Announces MOU with HighBreed Growth has Expired

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (CSE: $BEV.C) (TSX: $FAF.TO) (OTCQB: $GBLX) (NASDAQ: $NBEV)


Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (CSE: $BEV.C) (TSX: $FAF.TO) (OTCQB: $GBLX) (NASDAQ: $NBEV)



Delta, Kelowna, BC, December 20, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.


BevCanna Enterprises Inc. (CSE:BEV) (OTC :BVNNF) announced today that it has exercised its option to acquire the right, title and interest to DeeperGreen™, the proprietary water-soluble cannabinoid powder ingredient developed by partner Greener Frontiers.

"DeeperGreen technology expands BevCanna's ability to produce a portfolio of cannabis infused beverage formats," said Emma Andrews, Chief Commercialization Officer at BevCanna. "The addition of a water-soluble powder allows us to offer consumers more variety in methods of consumption, which can now pair with various consumption occasions. Powdered drink mixes complement our existing expertise in ready-to-drink products and allow us to expand the innovation pipeline for our house brands, and with white label partners through contract manufacturing."

DeeperGreen converts extracted cannabis into a fast-acting, tasteless, odorless, water-soluble powdered ingredient, and has been proven to be a stable ingredient that when tested with cannabinoids, consistently delivers target concentrations within one batch and from batch-to-batch. Independent laboratory testing has also confirmed that DeeperGreen precisely infuses granular drink mixes and ready-to-drink water beverages.

Tests have confirmed that DeeperGreen, and products infused with DeeperGreen, meet the criteria to pass the current Cannabis Compliance Regulations set in California, and will allow for reliable water-soluble infusion manufacturing processes and dosing confidence for consumers.

On December 18th, 2019, the Company entered into an amendment agreement to the Cannabis Beverage Joint Development Agreement dated April 1, 2019 with Greener Frontiers Corporation and BevCanna US Operating Company Ltd., a wholly-owned subsidiary of the Company. Pursuant to the Agreement, the Company exercised its right under the JD Agreement to purchase all of the right, title, and interest in and to DeeperGreen and certain other intellectual property assets of Greener Frontiers.

Fire & Flower Holdings Corp. (TSX: FAF) and its wholly-owned subsidiary Fire & Flower Inc. today announced that it has begun selling new "cannabis 2.0" product formats in its retail stores in the province of Saskatchewan.

The Company is among the first retailers in Canada to be selling these new product formats. This has been achieved through a private wholesale model in the province of Saskatchewan, where the Company's wholly-owned distribution business, Open Fields Distribution purchases from and negotiates prices directly with Licensed Producers.

New product formats in Fire & Flower's assortment will be composed of edibles including gummies, mints and chocolates; and concentrate vaporizers in both all-in-one and cartridge formats. Fire & Flower's initial assortment of cannabis 2.0 products in the province is anticipated to include offerings from the following Licensed Producers and brands prior to the end of 2019: Aphria, Aurora, Dosist, Cronos, The Green Organic Dutchman, High Park, Organigram, Redecan, and Sundial.

"With Fire & Flower being one of the first retailers in Canada to stock new cannabis formats, this exemplifies the clear benefits of the private distribution model including price, access and diversity of product within the province of Saskatchewan," shared Trevor Fencott, Fire & Flower's Chief Executive Officer. "We have demonstrated leadership through establishing Open Fields Distribution which supplies both the Fire & Flower retail network and external accounts within the province of Saskatchewan. There is significant demand for these new product formats in the market and we look forward to bringing these products to our loyal customers."

"Our team has worked diligently over the last year and we are thrilled to be launching our Solei, RIFF and Good Supply vaporizers in 510 and all-in-ones at Fire & Flower stores across the province of Saskatchewan," said Bernie Yeung, Vice President, Sales & Channel Strategy with Aphria Inc. "We are confident in our market readiness across the country and look forward to working closely with our retail partners to ensure we have the right brands and product offerings for consumers as we strive to combat the illicit market."

Fire & Flower will continue to monitor consumer preferences of new product formats using the Hifyre digital retail and analytics platform to judiciously manage its product assortment and inventory on-hand.

As new products, including beverages and topcials, become available, Fire & Flower expects to include these products in the Company's assortment, thereby increasing consumer choice of new product formats.

The Company does not yet have a confirmed date for the release of new cannabis product formats in provinces where government-owned provincial distributors control the supply chain.

GB Sciences, Inc. (OTCQB: GBLX) announced significant preclinical results for their Parkinson's disease formulations from the midterm report for their preclinical study being performed by Dr. Lee Ellis of the National Research Council (NRC) in Halifax, Nova Scotia, CANADA. GB Sciences' PD formulations were able to reduce behavioral changes associated with the loss of dopamine-producing neurons, which underlies the pathology of Parkinson's disease in the animal model. Our final phase of testing will study the mechanism of action for these promising formulations, which could potentially help patients with this debilitating disease. The combined direct and indirect costs associated with Parkinson's disease are estimated at $52 billion in the U.S. alone.

"Several of GB Sciences' mixtures were effective. In fact, our most effective mixture was able to 'rescue' the PD-like behavioral changes to the point where the treated animal's behavior was back to baseline. In addition, our PD formulas produced negligible side effects, which is equally important," explained Dr. Andrea Small-Howard, Chief Science Officer and Director of both GB Sciences, Inc. and GBS Global Biopharma, Inc. "These important preclinical results will be included as 'proof of concept' in GB Sciences' Investigational New Drug application with the US FDA in order to enter into our 'First-in-Man' human clinical trial as early as next year."

Central to the development of Parkinson's disease is the loss of dopamine-producing neurons. Reduced dopamine levels in the brain lead to movement disorders. GB Sciences' PD formulations may be protecting dopamine-producing neurons, or they may cause the surviving neurons to produce more dopamine to compensate for a loss in the number of dopamine-producing neurons. The final phase of GB Sciences' preclinical study will examine these and other possible mechanisms for their effectiveness. 

"These positive preclinical results suggest that our cannabinoid-containing complex mixtures may be useful for the treatment of Parkinson's disease symptomology," said Dr. Michael Farley, President and Director of GBS Global Biopharma, Inc.. "We look forward to bringing these promising formulations into human clinical trials as early as 2020."

New Age Beverages Corporation (NASDAQ: NBEV), the Colorado-based healthy products company, announced the launch of its hemp portfolio in Australia and New Zealand.

Under the umbrella of its Health Sciences Division, NewAge received approval and has begun selling its premium portfolio of hemp oils, creams and lotions in Australia and New Zealand. The launch initially features three distinct products:
  1. ‘NHANCED Hemp Body Cream in a 120 mL tub
  2. ‘NHANCED Hemp Roll-On Gel 90 mL roll-on
  3. ‘NHANCED Hemp Oil containing 30 mL tincture

The products will be sold immediately through more than 2,000 direct-to-consumer distribution partners across Australia and New Zealand.

“’NHANCED Hemp is proving to be one of our most talked about product lines we have launched,” said Brent Willis, Chief Executive Officer of NewAge. “Receiving approval and beginning to sell our products in these markets further puts us on the right path to become a leading player in the hemp/CBD industry in Australia and New Zealand.”

NewAge’s research and development teams and scientists worked exhaustively over the past year to develop the hemp specific formulas that both meet the regulatory requirements of markets like Australia and New Zealand but also maintained the efficacy, strength, and benefit of NewAge’s full strength CBD formulas.

“’NHANCED Hemp products were designed and developed to meet stringent government hemp (cannabis sativa) and cannabidiol (CBD) regulations for safety, purity and efficacy,” said Laura Kimball, director of product development. “The hemp in these three products is sourced from industrial hemp grown in the USA and the mature seed is then carefully processed to ensure that it is pure and completely free from tetrahydrocannabinol (THC).”

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android  

Contact Investorideas.com
800-665-0411

  





Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Investor Ideas adds New #Cannabis #Stocks (OTC: $PHBI) (CSE: $TFC.C) (CSE: $MJAR.C)(TSXV: $EVE.V)


Investor Ideas adds New #Cannabis #Stocks (OTC: $PHBI) (CSE: $TFC.C) (CSE: $MJAR.C)(TSXV: $EVE.V)



Point Roberts, WA, Delta BC – December 20, 2019 – Investorideas.com, a global news source and investor resource covering cannabis and hemp stocks announces this week’s additions to its cannabis /hemp stock directory for investors following the sector.


This week’s new companies are involved in tissue cultures working with hemp plants, specialty finance for the cannabis industry, cannabis management platforms and the production and sale of various cannabis products.

This week’s new Marijuana/Cannabis Stocks Added to the Investor cannabis stock directory:

MJardin Group, Inc  (CSE: MJAR) (OTCQX: MJARF) is a cannabis management platform with extensive experience in cultivation, processing, distribution and retail. For over 10 years, MJardin has refined cultivation methodologies, developed state of the art facilities and implemented vertical integration for and on behalf of license owners. MJardin is based in Denver, Colorado and Toronto, Canada.

Pharmagreen Biotech, Inc. (OTC Pink: PHBI) WFS Pharmagreen Inc. is a wholly owned Canadian based subsidiary of Pharmagreen Biotech, Inc., a publicly traded (OTC Pink: PHBI) company. WFS Pharmagreen Inc. is a tissue culture company that is becoming one of the largest producers of hemp plantlets through a proprietary tissue culture process with opportunity to become one of the largest players globally. Pharmagreen's mission is to advance the technology of tissue culture science and to provide the highest quality 100% germ free, disease free and all genetically the same hemp plantlets with high Cannabinoids content and with less than 0.3% THC and other flora while offering full spectrum DNA testing for plant identification, live genetics preservation using low temperature storage for various plant species.

Trichome Financial Corp. (CSE:TFC) is a specialty finance company focused on providing flexible and creative credit solutions to the global legal cannabis market. Trichome Financial was created to address the lack of credit availability in the large, growing and increasingly complex cannabis market. Founded by industry leaders Origin House and Stoic Advisory, Trichome Financial's experienced management team has a unique edge to capitalize on proprietary deal flow and industry insight while developing a first mover advantage as a global cannabis focused specialty finance company. Trichome Financial provides customized financing solutions across the industry value chain to support growth, capital expenditures, mergers, acquisitions, working capital and other needs.  Leveraging the combined resources and knowledge of its founders, it is able to offer significant value-added financial, product, market and operational support to its partner companies. Trichome Financial's current assets are all based in Canada and it currently has no operations or assets in the United States.

Eve & Co Incorporated (TSXV:EVE,OTC:EEVVF) through its wholly-owned subsidiary Natural MedCo Ltd., holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil. Natural MedCo Ltd. was Canada's first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co is led by a team of agricultural experts and has a licensed 1,000,000 square foot greenhouse located in Strathroy, Ontario.

For investors following the sector Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks.  Visit directory.

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about our news, PR and social media services at Investorideas.com

Follow us on cannabis social media
Download our Mobile App for iPhone and Android  

To sponsor a daily podcast for the month or to be an expert guest please contact us!

Contact Investorideas.com
800-665-0411



Get more Marijuana, hemp & cannabis stock investor ideas- news, articles, podcasts and stock directories








Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 438 (NASDAQ: $VFF) (CSE: $NOVA.C) (CSE: $LOVE.C) (OTCQB: $MGWFF)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 438 (NASDAQ: $VFF) (CSE: $NOVA.C) (CSE: $LOVE.C) (OTCQB: $MG...